E-LIB Suche - Ergebnisse für: Levis, Mark J.

1

Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leuk..:

Zhu, Ruiqi ; Shirley, Courtney M. ; Chu, S. Haihua...
Leukemia. , 2024

2

Health-Related Quality of Life with Gilteritinib Versus Pla..:

Hamilton, Betty K. ; Levis, Mark J. ; Pandya, Bhavik J...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S44-S45 , 2024

Link: https://doi.org/10.1016/..

3

A phase 1 study of the irreversible FLT3 inhibitor FF-10101..:

Levis, Mark ; Perl, Alexander ; Schiller, Gary...
Blood Advances. 8 (2024) 10 - p. 2527-2535 , 2024

Link: https://doi.org/10.1182/..

4

Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory..:

Perl, Alexander E. ; Larson, Richard A. ; Podoltsev, Nikolai A....
Transplantation and Cellular Therapy. 29 (2023) 4 - p. 265.e1-265.e10 , 2023

Link: https://doi.org/10.1016/..

5

PB1840: OUTCOME OF ADULT ACUTE MYELOID LEUKEMIA PATIENTS WI..:

Kayser, Sabine ; Sanber, Khaled ; Marconi, Giovanni...
HemaSphere. 7 (2023) S3 - p. e1610525 , 2023

Link: https://doi.org/10.1097/..

6

Impact of inotuzumab ozogamicin on outcome in relapsed or r..:

Kayser, Sabine ; Sartor, Chiara ; Giglio, Fabio...
Haematologica. , 2023

Link: https://doi.org/10.3324/..

7

Oral Abstract: CT-186 Impact of Allogeneic Hematopoietic Ce..:

Schlenk, Richard F. ; Montesinos, Pau ; Romero-Aguilar, Antonio...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S148 , 2023

Link: https://doi.org/10.1016/..

8

AML-132 QuANTUM-First Trial: FLT3–Internal Tandem Duplicati..:

Levis, Mark J. ; Erba, Harry P. ; Montesinos, Pau...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S272 , 2023

Link: https://doi.org/10.1016/..

9

Outcome heterogeneity of TP53-mutated myeloid neoplasms and..:

Pasca, Sergiu ; Haldar, Saurav D. ; Ambinder, Alexander...
Haematologica. 109 (2023) 3 - p. 948-952 , 2023

Link: https://doi.org/10.3324/..

10

POSTER: AML-132 QuANTUM-First Trial: FLT3–Internal Tandem D..:

Levis, Mark J. ; Erba, Harry P. ; Montesinos, Pau...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S166 , 2023

Link: https://doi.org/10.1016/..

11

POSTER: CT-186 Impact of Allogeneic Hematopoietic Cell Tran..:

Schlenk, Richard F. ; Montesinos, Pau ; Romero-Aguilar, Antonio...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S229 , 2023

Link: https://doi.org/10.1016/..

12

Co-occurring mutations in ASXL1, SRSF2, and SETBP1 define a..:

Jain, Tania ; Ware, Alisha D. ; Dalton, William Brian...
Leukemia Research. 131 (2023) - p. 107345 , 2023

Link: https://doi.org/10.1016/..

13

CT-186 Impact of Allogeneic Hematopoietic Cell Transplantat..:

Schlenk, Richard F. ; Montesinos, Pau ; Romero-Aguilar, Antonio...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S521-S522 , 2023

Link: https://doi.org/10.1016/..

14

S137: IMPACT OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATI..:

Schlenk, Richard ; Montesinos, Pau ; Romero-Aguilar, Antonio...
HemaSphere. 7 (2023) S3 - p. e61150fb , 2023

Link: https://doi.org/10.1097/..

15

The clinical impact of the molecular landscape of acute mye..:

Kayser, Sabine ; Levis, Mark J.
Haematologica. 108 (2023) 2 - p. 308-320 , 2023

Link: https://doi.org/10.3324/..